Dow Up 1.13% Nasdaq Up 1.41%

BioTime, Inc. (BTX)

-NYSE MKT
3.39 Down 0.08(2.31%) Oct 31, 4:02PM EDT
Prev Close:3.47
Open:3.51
Bid:3.15 x 1000
Ask:3.55 x 300
1y Target Est:8.00
Beta:1.09
Next Earnings Date:N/A
Day's Range:3.30 - 3.55
52wk Range:2.21 - 4.18
Volume:252,418
Avg Vol (3m):254,635
Market Cap:226.69M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BTX

Comparison

Symbol% ChgMkt Cap
BTXDown 2.31%226.69M
BAXUp 0.11%37.99B
HSPDown 1.00%9.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):48.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioTime, Inc., a biotechnology company, is engaged in the research and product development in the field of regenerative medicine. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback